FDA Cleared
Existing Device (Modification)
Pathway: 510K
Cleerly ISCHEMIA
Applicant:
Cleerly, Inc.
Statutory Profile
Legal Standard:
Substantial Equivalence (SE) to predicate (21 CFR 807)
Product Code:
QXZ
Review Panel:
Cardiovascular
21 CFR Regulation:
8
Review Velocity Metrics
Date Received:
2026-08-11
Decision Date:
2026-10-29
Total Review Duration:
79 calendar days (79 days)
Official FDA Research Backlinks
Direct links to primary official records hosted by the U.S. Food and Drug Administration CDRH databases:
Identified Contacts & Correspondents
Ivan Pulido
Role: SUBMITTER_CONTACT
Notice a discrepancy or outdated information on this record?
Report to support@fdacleared.org